News and Announcements
Pacific Knowledge Systems IPO roadshow Kicks off with the hope to raise $22 Million
- Published December 02, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Bombora Investment Management are the lead investor in an exciting IPO for a high growth and profitable healthcare technology company called Pacific Knowledge Systems (PKS).
The companies IPO roadshow kicked off last week with the aim to raise $22 Million. Bombora Investment Management are offering the opportunity to meet the company during the IPO roadshow.
About Bombora Investment Management are the lead investor in an exciting IPO for a high growth and profitable healthcare technology company called Pacific Knowledge Systems (PKS).
About Pacific Knowledge Systems
PKS is a healthcare technology company which provides a proprietary subscription based Clinical Decision Support (CDS) system called “RippleDown” that automates the human decision-making process in health care organisations. PKS represents a potential opportunity to participate in the large and fast growing global Healthcare IT solutions market.
In summary, PKS is profitable and has great growth ambitions with the RippleDown software product used by pathology and hospital departments to increase efficiency of patient interpretations and the financial accuracy of all billing movements.
RippleDown has two components that address a number of the key issues faced by healthcare organisations:
- RippleDown Auditor: that enables operational efficiencies through a reduction in data entry errors; and
- RippleDown Expert: that allows faster patient throughput, better patient outcomes and mitigates succession risk.
The Offer
PKS is raising $22.0m from the IPO (Offer) and expects to commence trading in January 2019 under the ticker “PKS”
If you are interested in attending the roadshow, the company has provided a special allocation using the following link: www.netroadshow.com/nrs/home/#!/?show=d27efe24
If required, deal entry code is “PKS93”.
RippleDown has been successfully implemented at a range of healthcare organisations globally and has three partnerships with international channel partners Abbott, Phillips and Thermo-Fisher. It is a highly scalable, subscription-based technology offering with annuity style revenue streams.
PKS has a highly experienced board consisting of healthcare operators and investment professionals, including:
- Mike Hill (Bombora)
- Chris Smith (ex CEO of Cochlear)
- Paul Williams (ex CIO of Healthscope)
- Andrew Gray (Potentia Capital – Software Investor)
- Neil Broekhuizen (Board of Bravura Limited and Monash IVF)
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
